Human Papillomavirus Anal Infection

Centre Hospitalier Universitaire de Besancon500 enrolled

Overview

Human papillomavirus (HPV) are involved in up to 95 % of anal canal neoplastic lesions. Little is known about HPV carriage in anal canal previous to cancer occurrence in the population and pre-neoplastic lesions, and their risk factors. PAPILLAN is a prospective study that aims to study HPV infection (HPV low grade and high grade genotypes) prevalence in anal canal in a population non selected by its HIV status. In that purpose patients are prospectively recruited in a french university hospital gastroenterology unit and anal smears are collected during a colonoscopy with cytobrush.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

500

Conditions

HPV Infection

Interventions

HPV detection in anal canal samplesPROCEDURE

Additional anal taking during the colonoscopy with cytobrush

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients \> 18 years * patients undergoing colonoscopy under general anesthesia for any purpose * signed written consent Exclusion Criteria: * age under 18 * Absence of written consent. * patients incapable of giving consent

Locations (2)

Centre Hospitalier Régional Universitaire de Besançon

Besançon, France

Centre Hospitalier Intercommunal de la Haute Saône

Vesoul, France

Outcomes

Primary Outcomes

anal canal HPV infection

Time frame: at inclusion (the day of colonoscopy)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.